LOGIN  |  REGISTER
C4 Therapeutics

Option Care Health (NASDAQ: OPCH) Stock Quote

Last Trade: US$30.42 -0.99 -3.15
Volume: 1,096,237
5-Day Change: -3.95%
YTD Change: -9.71%
Market Cap: US$5.290B

Latest News From Option Care Health

BANNOCKBURN, Ill., April 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2024 on Tuesday, April 23, 2024 before the market opens. In conjunction, the management team will host a conference call to review... Read More
BANNOCKBURN, Ill., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights Net revenue of $1,124.4 million, up 9.5% compared to $1,027.2 million... Read More
BANNOCKBURN, Ill., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its fourth quarter and full year ended December 31, 2023 on Thursday, February 22, 2024 before the market opens. In conjunction, the management team will host a... Read More
DENVER & BANNOCKBURN, Ill. / Jan 08, 2024 / Business Wire / Palantir Technologies Inc. (NYSE: PLTR), a leading provider of AI systems, and Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, today announced a multi-year commercial partnership for Palantir’s software to be leveraged across the company to help improve... Read More
BANNOCKBURN, Ill., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the 42nd Annual J.P. Morgan Healthcare Conference, being held in San Francisco, on Tuesday, January 9, 2024, including a presentation at 3:00pm PT. The webcast and related presentation materials... Read More
BANNOCKBURN, Ill., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today that it anticipates completing the remaining $75 million of repurchases in the fourth quarter under the original authorization. In addition, the Company’s Board of Directors approved an... Read More
BANNOCKBURN, Ill., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: Jefferies London Healthcare Conference, being held in London, on Tuesday, November 14, 2023, including a fireside chat at 10:30am GMT/5:30am ET. Bank... Read More
BANNOCKBURN, Ill., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Financial Results and Highlights Net revenue of $1,093.0 million, up 7.1% compared to $1,020.9 million in... Read More
BANNOCKBURN, Ill., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2023 on Wednesday, October 25, 2023 before the market opens. In conjunction, the management team will host a conference call to... Read More
BANNOCKBURN, Ill., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the Morgan Stanley 21st Annual Global Healthcare Conference, being held in New York, on Tuesday, September 12, 2023, including a fireside chat at 2:55pm ET. About Option Care Health Option Care... Read More
BANNOCKBURN, Ill., July 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Financial Results and Highlights Net revenue of $1,069.1 million, up 9.0% compared to $980.8 million in the... Read More
BANNOCKBURN, Ill., July 06, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2023 on Thursday, July 27, 2023 before the market opens. In conjunction, the management team will host a conference call to review... Read More
Highlights Strength of Platform and Track Record of Execution and Value Creation BANNOCKBURN, Ill. , June 26, 2023 /PRNewswire/ -- Option Care Health, Inc. ("Option Care Health" or the "Company") (Nasdaq: OPCH) today announced that it has terminated its previously announced agreement to combine with Amedisys, Inc. ("Amedisys"). As part of the mutual termination agreement, Option Care Health will receive a $106 million... Read More
Issues Statement in Light of Amedisys' Disclosure of Unsolicited Proposal from Optum BANNOCKBURN, Ill. , June 5, 2023 /PRNewswire/ -- Option Care Health, Inc. ("Option Care Health") (Nasdaq: OPCH) today filed with the U.S. Securities and Exchange Commission a registration statement on Form S-4 containing a joint proxy statement/prospectus in connection with its proposed merger with Amedisys, Inc. ("Amedisys"). In light of... Read More
Company to Deliver to Patients FDA-Approved Topical Treatment for Dystrophic Epidermolysis Bullosa (DEB) Announces Collaboration with Amedisys to Administer Treatment in the Home BANNOCKBURN, Ill., May 23, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH) today announced that it was selected by Krystal Biotech, Inc. (“Krystal Biotech”) (Nasdaq: KRYS) as part of a limited distribution... Read More
BANNOCKBURN, Ill., May 18, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: William Blair’s 43rd Annual Growth Stock Conference, being held in Chicago, on Tuesday, June 6, 2023, including a fireside chat at 11:30am CT. The... Read More
BANNOCKBURN, Ill., May 05, 2023 (GLOBE NEWSWIRE) - - Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will present at the BofA Securities Health Care Conference on Tuesday, May 9, 2023 in Las Vegas. John Rademacher, Chief Executive Officer, and Mike Shapiro, Chief Financial Officer, are scheduled to present at... Read More
All-Stock Transaction Combines Highly Complementary Businesses Unlocking Significant Benefits for Patients, Providers, Payers, and Care Teams Increases Access to High Quality Care for Communities Across the U.S. through a Unique National Clinical Platform Comprehensive Capabilities Across Alternate Site Care Spectrum Position Combined Company to Move Deeper into Value-Based Care Highly Attractive Combined Financial Profile... Read More
BANNOCKBURN, Ill. , May 3, 2023 /PRNewswire/ -- Option Care Health, Inc. (the "Company" or "Option Care Health") (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2023. First Quarter 2023 Financial Results and Highlights Net revenue of $1,015.8 million , up 10.9% compared to $915.8 million in the... Read More
BANNOCKBURN, Ill., April 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH) announces the formation of a nationwide home infusion nursing network and clinical platform that will operate as Naven Health, Inc. (“Naven Health”), focused on delivering specialized, truly exceptional infusion care. Naven Health employs over 1,500 nurses across the country with the ability to provide care in... Read More
BANNOCKBURN, Ill., April 18, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2023 on Thursday, May 4, 2023 before the market opens. In conjunction, the management team will host a conference call to review... Read More
BANNOCKBURN, Ill., March 01, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the “Selling Stockholder”) has agreed to sell 13,000,000 shares of the Company’s common stock at a price to the public of $30.75 per share in an underwritten secondary offering. The offering is expected to close on March 3,... Read More
BANNOCKBURN, Ill., March 01, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the “Selling Stockholder”) has agreed to sell 13,000,000 shares of the Company’s common stock in an underwritten secondary offering. The Company will not receive any proceeds from the offering. Goldman Sachs & Co. LLC is... Read More
BANNOCKBURN, Ill., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter 2022 Financial Highlights Net revenue of $1,027.2 million, up 10.8% compared to $927.2 million... Read More
BANNOCKBURN, Ill., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its fourth quarter and full year ended December 31, 2022 on Thursday, February 23, 2023 before the market opens. In conjunction, the management team will host a... Read More
BANNOCKBURN, Ill., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 in San Francisco. John Rademacher, Chief Executive Officer, and Mike Shapiro, Chief Financial Officer, are scheduled... Read More
Surmodics

COPYRIGHT ©2023 HEALTH STOCKS HUB